{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"53.0","upperLimit":"61.4","value":"57.2"},{"groupId":"OG001","lowerLimit":"55.2","upperLimit":"63.6","value":"59.4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"540"},{"groupId":"OG001","value":"525"}],"units":"Participants"}],"description":"FACT-P is a 39-item participant questionnaire that measures the concerns of participants with prostate cancer. It consists of 5 sub-scales assessing physical well-being (7 items), social/family well-being (7 items), emotional well-being (6 items), functional well-being (7 items), and prostate-specific concerns (12 items). FACT-P Total Score sums all 5 sub-scales to give a score in the range of 0 to 156, where higher values represent better HRQoL. Responder of FACT-P was defined as at least one occurrence of 7-point improvement from baseline in FACT-P total score during treatment period.","dispersionType":"95% Confidence Interval","groups":[{"description":"Cabazitaxel 20 mg/m\\^2 IV infusion over 1 hour on Day 1 of each 21-day cycle in combination with Prednisone (or Prednisolone) 10 mg orally daily until DP, unacceptable toxicity, participant's refusal of further study treatment or for a maximum of 10 cycles.","id":"OG000","title":"Cabazitaxel 20 mg/m^2"},{"description":"Cabazitaxel 25 mg/m\\^2 IV infusion over 1 hour on Day 1 of each 21-day cycle in combination with Prednisone (or Prednisolone) 10 mg orally daily until DP, unacceptable toxicity, participant's refusal of further study treatment or for a maximum of 10 cycles.","id":"OG001","title":"Cabazitaxel 25 mg/m^2"}],"paramType":"NUMBER","populationDescription":"Analysis was performed on FACT-P population. Number of participants analyzed= participants with evaluable FACT-P total score for specified outcome measure.","reportingStatus":"POSTED","timeFrame":"From baseline until DP, start of another anti-cancer therapy, death or study cut-off date (maximum duration: 48 months)","title":"Percentage of Participants With FACT-P Total Score Response","type":"SECONDARY","unitOfMeasure":"percentage of participants"}